Evidence map›Paper›PMID 36773626›Full record

ArticleThe lancet. HIV2023

Need for clear inclusion criteria in reviews of antiretroviral treatments - Authors' reply.

Kevin M Gibas, Jose R Arribas, Pedro Cahn, Eric S Daar, Babafemi O Taiwo

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The lancet. HIV, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kevin M GibasVanderbilt University Medical Center, Division of Infectious Diseases, Nashville, TN, USA.
Jose R ArribasLa Paz University Hospital-IdiPAZ, Infectious Diseases Unit, Madrid, Spain; Universidad Autónoma de Madrid, School of Medicine, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
Pedro CahnFundación Huesped, Buenos Aires, Argentina.
Eric S DaarThe Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
Babafemi O TaiwoNorthwestern University Feinberg School of Medicine, Division of Infectious Diseases, Chicago, IL, USA. Electronic address: b-taiwo@northwestern.edu.

Funding

Learning Health System training program: PROgRESS--Patient/ pRactice Outcomes and Research in Effectiveness and Systems ScienceT32HS026122 · AHRQ · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GRIJALVA, CARLOS G, ROUMIE, CHRISTIANNE L. · 2018 to 2024
$3.5M
AHRQ HHS T32 HS026122NIAID NIH HHS L30 AI172003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-HIV AgentsHIV InfectionsAnti-Retroviral AgentsHumansAnti-HIV AgentsAnti-Retroviral Agents

Identifiers

PMID36773626
PMCPMC10022476

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.